Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Amann, R; Peskar, BA; Schuligoi, R.
Effects of terbutaline on NGF formation in allergic inflammation of the rat.
Br J Pharmacol. 2001; 133(1):186-192 Doi: 10.1038/sj.bjp.0704060 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

Führende Autor*innen der Med Uni Graz
Amann Rainer
Co-Autor*innen der Med Uni Graz
Peskar Bernhard
Schuligoi Rufina
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
1. The aim of this study was to determine the effects of the beta adrenergic agonist terbutaline on NGF increase caused by allergic inflammation in rats. 2. Intraplantar antigen injection in sensitized rats increased paw volume and stimulated NGF biosynthesis in the skin of the injected paw as determined 3 and 6 h after injection. Treatment of rats with terbutaline (0.1 - 0.3 mg kg(-1), s.c.) had no significant effect on the NGF concentration in non-inflamed skin, but reduced oedema, and at 0.3 mg kg(-1) also NGF mRNA and immunoreactive NGF in the skin of the inflamed paw in a propranolol-reversible manner. In carrageenan-induced inflammation, terbutaline did not significantly reduce the inflammation-induced increase of NGF in paw skin. 3. Exposure of sensitized rats to aerosolized antigen (twice, 24 h interval) increased protein content, eosinophil leukocytes, and immunoreactive NGF in the bronchoalveolar lavage fluid (BAL, obtained 16 h after the second antigen exposure). Treatment of rats with terbutaline (0.3 mg kg(-1), s.c. 30 min before the second antigen challenge) suppressed antigen-induced elevation of protein and eosinophil leukocytes, and reduced the concentration of NGF in BAL to values similar to those found in non-sensitized rats. 4. The present results demonstrate anti-allergic properties of terbutaline in rats that were accompanied by a marked reduction of antigen-induced NGF increase in skin and BAL, respectively. These results are compatible with the assumption that terbutaline primarily suppressed the immune response to antigen thereby attenuating the release of vasoactive mediators and the stimulation of NGF biosynthesis.
Find related publications in this database (using NLM MeSH Indexing)
Adrenergic beta-Agonists - pharmacology
Adrenergic beta-Antagonists - pharmacology
Animals - pharmacology
Antigens - immunology
Bronchoalveolar Lavage - immunology
Edema - drug therapy
Eosinophils - immunology
Hindlimb - drug effects
Hypersensitivity - drug therapy
Inflammation - drug therapy
Male - drug therapy
Nerve Growth Factor - biosynthesis
Propranolol - pharmacology
RNA, Messenger - genetics
Rats - genetics
Rats, Sprague-Dawley - genetics
Reverse Transcriptase Polymerase Chain Reaction - genetics
Terbutaline - antagonists and inhibitors

Find related publications in this database (Keywords)
nerve growth factor
allergic inflammation
terbutaline
© Med Uni Graz Impressum